References
- The International Study of Asthma and Allergies in Childhood Steering Committee. Worldwide variations in the prevalence of asthma symptoms: the International Study of Asthma and Allergies in Childhood (ISAAC). Eur Respir J 1998; 12: 315–335
- Currie G P, Jackson C M, Lipworth B J. Does bronchial hyperresponsiveness in asthma matter?. J Asthma 2004; 41: 247–258
- Wardlaw A J. Molecular basis for selective eosinophil trafficking in asthma: a multistep paradigm. J Allergy Clin Immunol 1999; 104: 917–926
- Kharitonov S A, Yates D, Robbins R A, Kharitonov S A, Yates D, Robbins R A, Logan–Sinclair R, Shinebourne E A, Barnes P J. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343: 133–135
- Festa A, D'Agostino R, Jr, Tracy R P, Haffner S M. Elevated levels of acutephase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes 2002; 51: 1131–1137
- Pradhan A D, Manson J E, Rifai N, Buring J E, Ridker P M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327–334
- Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann M M, Ristow M, Boeing H, Pfeiffer A F. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003; 52: 812–817
- Hu F B, Meigs J B, Li T Y, Rifai N, Manson J E. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004; 53: 693–700
- Renauld J C. New insights into the role of cytokines in asthma. J Clin Pathol 2001; 54: 577–589
- Barnes P J. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 269–280
- The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160–3167
- Liverko I V. [Assessment of postload glycemic curves in the prediction of carbohydrate metabolic disturbances in patients with bronchial asthma]. Probl Tuberk Bolezn Legk 2005; 1: 50–54
- Al-Shawwa B A, Al-Huniti N H, DeMattia L, Gershan W. Asthma and insulin resistance in morbidly obese children and adolescents. J Asthma 2007; 44: 469–473
- Kiviranta K, Turpeinen M. Effect of eight months of inhaled beclomethasone dipropionate and budesonide on carbohydrate metabolism in adults with asthma. Thorax 1993; 48: 974–978
- Canis R, Demirkok S S, Osar Z, Balci H, Can G. Effects of inhaled budesonide on insulin sensitivity in nondiabetic patients with asthma and chronic obstructive pulmonary disease. Adv Ther 2007; 24: 560–570
- Faul J L, Cormican L J, Tormey V J, Tormey W P, Burke C M. Deteriorating diabetic control associated with high-dose inhaled budesonide. Eur Respir J 1999; 14: 242–243
- Faul J L, Tormey W, Tormey V, Burke C. High dose inhaled corticosteroids and dose dependent loss of diabetic control. BMJ 1998; 317(7171)1491
- Hashimoto Y, Nakahara K. Improvement of asthma after administration of pioglitazone. Diabetes Care 2002; 25: 401
- Rana J S, Mittleman M A, Sheikh J, Hu F B, Manson J E, Colditz G A, Speizer F E, Barr R G, Camargo C A, Jr. Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. Diabetes Care 2004; 27: 2478–2484